The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

W, Hacke; G, Albers; Y, Al-Rawi; J, Bogousslavsky; A, Davalos; M, Eliasziw; M, Fischer; A, Furlan; M, Kaste; KR, Lees; M, Soehngen; S, Warach

doi:10.1161/01.str.0000149938.08731.2c

Public

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Shared by NobleBlocks on Nov 29, 2004 • 12:00 AM UTC

Authors:

Hacke W

Albers G

Al-Rawi Y

Abstract

Background and purpose Most acute ischemic stroke patients arrive after the 3-hour time window for recombinant tissue plasminogen activator (rtPA) administration. The Desmoteplase In Acute Ischemic Stroke trial (DIAS) was a dose-finding randomized trial designed to evaluate the safety and efficacy o...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!